Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tiger Balsam Soft is a topical ointment developed and marketed by Evolan Pharma, designed as a softer variant of the traditional Tiger Balsam. It contains a combination of four active ingredients: cajuput oil, levomenthol, racemic camphor, and clove oil. These components function as counter-irritants that stimulate sensory receptors in the skin, locally increasing blood flow and providing a dual cooling and warming sensation. This mechanism helps to indirectly relieve pain and discomfort associated with muscle aches, joint pain, strains, and sprains. Additionally, Tiger Balsam Soft is indicated for the symptomatic relief of uncomplicated insect bites and the alleviation of upper respiratory symptoms during the common cold. It is an approved over-the-counter medication known for its smooth consistency and application-friendly formulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tiger Balsam Soft.